Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).

Strategic collaboration to enable streamlined and accelerated access to Shield blood-based colorectal cancer screening test across Quest’s vast network Physicians nationwide now have the ability to ...

Colorectal cancer is the second-leading cause of cancer-related death in the U.S., even though it is highly treatable if caught early.2 The American Cancer Society estimates that more than 150,000 ...

The test, which screens for DNA that is released when cancer cells die, is now one of multiple options for colorectal cancer screening. Guardant Health's Shield blood test for colorectal cancer ...

ACOG issued updated guidelines on screening for cervical cancer that align with recent recommendations from the Health ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced the launch of Shield Across America, a historic coast-to-coast mobile ...

You've come this far — now prepare yourself for the next half-century.

The vision of a single blood test that could screen for dozens of different cancers has tantalized oncologists for more than ...

(NEXSTAR) — An unexpected delivery at your door may not always be an unwelcome surprise — just ask one Kentucky boy about the thousands of dollars worth of lollipops that arrived at his home earlier ...

Monroe County residents can access $20 blood tests, vaccines and more at spring Health Check events in Temperance and Dundee ...